The Use of the Oxygenation Stretch Index to Predict Outcomes in Mechanically Ventilated Patients With COVID-19 ARDS.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
25 Nov 2023
Historique:
pmc-release: 01 12 2024
medline: 27 11 2023
pubmed: 5 7 2023
entrez: 4 7 2023
Statut: epublish

Résumé

In ARDS caused by COVID-19 pneumonia, appropriate adjustment of physiologic parameters based on lung stretch or oxygenation may optimize the ventilatory strategy. This study aims to describe the prognostic performance on 60-d mortality of single and composite respiratory variables in subjects with COVID-19 ARDS who are on mechanical ventilation with a lung-protective strategy, including the oxygenation stretch index combining oxygenation and driving pressure (ΔP). This single-center observational cohort study enrolled 166 subjects on mechanical ventilation and diagnosed with COVID-19 ARDS. We evaluated their clinical and physiologic characteristics. The primary study outcome was 60-d mortality. Prognostic factors were evaluated through receiver operating characteristic analysis, Cox proportional hazards regression model, and Kaplan-Meier survival curves. Mortality at day 60 was 18.1%, and hospital mortality was 22.9%. Oxygenation, ΔP, and composite variables were tested: oxygenation stretch index ([Formula: see text]/[Formula: see text] divided by ΔP) and ΔP × 4 + breathing frequency (f) (ΔP × 4 + f). At both day 1 and day 2 after inclusion, the oxygenation stretch index had the best area under the receiver operating characteristic curve (oxygenation stretch index on day 1 0.76 (95% CI 0.67-0.84) and on day 2 0.83 (95% CI 0.76-0.91) to predict 60-d mortality, although without significant difference from other indexes. In multivariable Cox regression, ΔP, [Formula: see text]/[Formula: see text], ΔP × 4 + f, and oxygenation stretch index were all associated with 60-d mortality. When dichotomizing the variables, ΔP ≥ 14, [Formula: see text]/[Formula: see text] ≤ 152 mm Hg, ΔP × 4 + f ≥ 80, and oxygenation stretch index < 7.7 showed lower 60-d survival probability. At day 2, after optimization of ventilatory settings, the subjects who persisted with the worse cutoff values for the oxygenation stretch index showed a lower probability of survival at 60 d compared with day 1; this was not the case for other parameters. The oxygenation stretch index, which combines [Formula: see text]/[Formula: see text] and ΔP, is associated with mortality and may be useful to predict clinical outcomes in COVID-19 ARDS.

Sections du résumé

BACKGROUND BACKGROUND
In ARDS caused by COVID-19 pneumonia, appropriate adjustment of physiologic parameters based on lung stretch or oxygenation may optimize the ventilatory strategy. This study aims to describe the prognostic performance on 60-d mortality of single and composite respiratory variables in subjects with COVID-19 ARDS who are on mechanical ventilation with a lung-protective strategy, including the oxygenation stretch index combining oxygenation and driving pressure (ΔP).
METHODS METHODS
This single-center observational cohort study enrolled 166 subjects on mechanical ventilation and diagnosed with COVID-19 ARDS. We evaluated their clinical and physiologic characteristics. The primary study outcome was 60-d mortality. Prognostic factors were evaluated through receiver operating characteristic analysis, Cox proportional hazards regression model, and Kaplan-Meier survival curves.
RESULTS RESULTS
Mortality at day 60 was 18.1%, and hospital mortality was 22.9%. Oxygenation, ΔP, and composite variables were tested: oxygenation stretch index ([Formula: see text]/[Formula: see text] divided by ΔP) and ΔP × 4 + breathing frequency (f) (ΔP × 4 + f). At both day 1 and day 2 after inclusion, the oxygenation stretch index had the best area under the receiver operating characteristic curve (oxygenation stretch index on day 1 0.76 (95% CI 0.67-0.84) and on day 2 0.83 (95% CI 0.76-0.91) to predict 60-d mortality, although without significant difference from other indexes. In multivariable Cox regression, ΔP, [Formula: see text]/[Formula: see text], ΔP × 4 + f, and oxygenation stretch index were all associated with 60-d mortality. When dichotomizing the variables, ΔP ≥ 14, [Formula: see text]/[Formula: see text] ≤ 152 mm Hg, ΔP × 4 + f ≥ 80, and oxygenation stretch index < 7.7 showed lower 60-d survival probability. At day 2, after optimization of ventilatory settings, the subjects who persisted with the worse cutoff values for the oxygenation stretch index showed a lower probability of survival at 60 d compared with day 1; this was not the case for other parameters.
CONCLUSIONS CONCLUSIONS
The oxygenation stretch index, which combines [Formula: see text]/[Formula: see text] and ΔP, is associated with mortality and may be useful to predict clinical outcomes in COVID-19 ARDS.

Identifiants

pubmed: 37402585
pii: respcare.10903
doi: 10.4187/respcare.10903
pmc: PMC10676243
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1683-1692

Informations de copyright

Copyright © 2023 by Daedalus Enterprises.

Références

Ann Am Thorac Soc. 2019 Oct;16(10):1263-1272
pubmed: 31247145
Ann Am Thorac Soc. 2020 Sep;17(9):1158-1161
pubmed: 32432896
J Trauma Acute Care Surg. 2014 Feb;76(2):469-73
pubmed: 24458052
Intensive Care Med. 2020 Dec;46(12):2200-2211
pubmed: 32728965
Intensive Care Med. 2016 Oct;42(10):1567-1575
pubmed: 27620287
Intensive Care Med. 2016 Dec;42(12):1865-1876
pubmed: 27757516
Intensive Care Med. 2019 Dec;45(12):1835-1837
pubmed: 31595350
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836
pubmed: 31034248
Crit Care Med. 2016 Jan;44(1):32-42
pubmed: 26672923
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
N Engl J Med. 2013 Jun 6;368(23):2159-68
pubmed: 23688302
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Intensive Care Med. 2019 Jun;45(6):856-864
pubmed: 31062050
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1210-6
pubmed: 9351624
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Intensive Care Med. 2018 Nov;44(11):1914-1922
pubmed: 30291378
Intensive Care Med. 2022 Jul;48(7):888-898
pubmed: 35670818
Am J Respir Crit Care Med. 2021 Aug 1;204(3):303-311
pubmed: 33784486
Intensive Care Med Exp. 2019 Nov 27;7(1):61
pubmed: 31773328
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Crit Care. 2017 Apr 4;21(1):84
pubmed: 28372575
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
Intensive Care Med. 2020 Dec;46(12):2187-2196
pubmed: 33089348
Intensive Care Med. 2019 Jan;45(1):97-98
pubmed: 30006893
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Am J Respir Crit Care Med. 2019 Feb 1;199(3):333-341
pubmed: 30211618
Intensive Care Med. 2019 Apr;45(4):557-558
pubmed: 30523357
Intensive Care Med. 2021 Dec;47(12):1426-1439
pubmed: 34585270
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet Respir Med. 2021 Feb;9(2):139-148
pubmed: 33169671
Ann Am Thorac Soc. 2018 Jun;15(6):754-759
pubmed: 29856252
Chest. 1992 Sep;102(3):918-23
pubmed: 1516422
Crit Care Med. 1992 Oct;20(10):1461-72
pubmed: 1395670
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Crit Care. 2016 Nov 29;20(1):384
pubmed: 27894328
Anesthesiology. 2016 May;124(5):1100-8
pubmed: 26872367
Am J Respir Crit Care Med. 2020 Jan 15;201(2):178-187
pubmed: 31577153
BMJ. 2021 Mar 9;372:n611
pubmed: 33687923
Crit Ultrasound J. 2016 Dec;8(1):8
pubmed: 27496127
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Am J Respir Crit Care Med. 2017 Oct 1;196(7):822-833
pubmed: 28306327
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Am J Respir Crit Care Med. 2006 Aug 1;174(3):268-78
pubmed: 16690982
Crit Care Med. 2005 Mar;33(3 Suppl):S217-22
pubmed: 15753731

Auteurs

Rollin Roldán (R)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú. rollinroldan@yahoo.es.

Fernando Barriga (F)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Renán Villamonte (R)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Franco Romaní (F)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Mauro Tucci (M)

UTI Respiratoria, Divisao de Pneumologia, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Arturo Gonzales (A)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Paolo Wong (P)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Jorge Zagaceta (J)

Facultad de Medicina Humana, Universidad de Piura, Lima, Perú. Drs Roldán, Barriga, and Villamonte are affiliated with the Intensive Care Unit, Hospital Rebagliati, Lima, Perú.

Laurent Brochard (L)

Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Canada. Dr Brochard is affiliated with the Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH